Victoria J. Orphan: Deep Partnerships

Credit: © Ric Frazier Productions" /> Credit: © Ric Frazier Productions Victoria Orphan wanted to be a marine biologist ever since kindergarten. She even wrote it down in a Dr. Seuss book called My Book About Me. It still sits in her childhood bedroom, which she had painted to resemble a deep-sea scene. At the University of California, Santa Barbara, Orphan studied marine biology and was headed in the direction of big-game ecology when she took a course with Ed DeLong,

Written byStuart Jacobson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Victoria Orphan wanted to be a marine biologist ever since kindergarten. She even wrote it down in a Dr. Seuss book called My Book About Me. It still sits in her childhood bedroom, which she had painted to resemble a deep-sea scene.

At the University of California, Santa Barbara, Orphan studied marine biology and was headed in the direction of big-game ecology when she took a course with Ed DeLong, now a microbiologist at Massachusetts Institute of Technology. She had a realization. Methodological advances, especially in phylogenetics, were beginning to open new doors for microbiologists. Meanwhile, she says, "There were too many questions and not enough answers in microbial ecology."

Orphan did her doctorate work under DeLong, and he encouraged her to go to the Monterey Bay Aquarium Research Institute, where her work carried her to the sea floor. She studied anaerobic oxidation of methane in ocean sediments. The process ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies